Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft modelsClarisse Thiollier, Thomas Mercher, Cécile K. Lopez et al.|The Journal of Experimental Medicine|2012Cited by 108
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Muriel Gaudry et al.|Clinical Cancer Research|2020Cited by 23
Figure S7 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0
Supplementary Data from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Aurélie Siret et al.|Unknown|2023Cited by 0
Supplementary Table 3 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P. Laurent, Sébastien Malinge, Zakia Aid et al.|Unknown|2023Cited by 0